维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Largillier"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	基于层次分析过程(AHP)的汽车人机交互界面(HMI)逻辑框架的分析及设计显示文摘如今,做决策十分重要,企业尤其如此,其结果直接导致获利或亏损。有时,决策错综复杂,我们需要评估多个相关因素。另一个重要的决策制定过程存在于产品开发之中,由于直接影响产品能否被市场接受,其后果更为严重。本文将评估使用层次分析过程(AHP)作为产品开发过程决策工具的可行性。这种方法由Thomas Saaty开发,通过结合经验、判断和直觉为用户从多变量中制定最佳行为过程提供支持。为挑选出产品最佳性能的最优特性,本文着重对汽车人机交互界面(HMI)的逻辑框架进行分析与设计。这里介绍的工具通过建立产品评价标准的层次获得。研究过程中,我们制定了构建层次的标准并最终应用在搭载于一些现存大型车辆上含四变量的人机交互逻辑框架中。	Edouard-Thomas LARGILLIER 马钧徐雯霞	2013	汽车实用技术2013，10，9：	5
2	Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer显示文摘	P. Fumoleau R. Largillier C. Clippe V. Dièras H. Orfeuvre T. Lesimple S. Culine B. Audhuy D. Serin H. Curé E. Vuillemin J.-F. Morère F. Montestruc Z. Mouri M. Namer	2003	European Journal of Cancer2003，，4：	2
3	Pharmacogenetics of capecitabine in advanced breast cancer patients显示文摘	Largillier R Etienne-Grimaldi MC Formento JL	2006	Clin Cancer Res2006，12，18：	1
4	Muhicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor - 2 - overexpressing stage I显示文摘	Coudert BP Largillier R Arnould L	2007	J Clin Oncol2007，25，19：	1
5	Phase II study of capecitabine ( Xeloda ) in pts with advanced breast cancer ( ABC ), previously treated with anthracyclines and taxanes显示文摘	Fumoleau P Largillier R Trillet-Lenoir V	2001	Breast Catwer Res Treat2001，69，：	1
6	Aromatase inhibition in male breast cancer patients: biological and clinical implications显示文摘	Doyen J Italiano A Largillier R etal	2010	Ann Oneol2010，21，6：	1
7	Multicentre,phase II study evaluating capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer显示文摘	Fumoleau P largillier R Clippe C	2004	Eur J Cancer2004，40，4：	1
8	Multicentre phase Ⅱ study evaluting capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastic breast cancer显示文摘	Fumoleau P Largillier R Clippe C	2004	Eur J Cancer2004，40，4：	1
9	Multicentre, phase I1 study evaluating eapecitabine monotherapy in patients with anthra- cyclin-and taxane-pretreated metastatic breast cancer 显示文摘	Fumoleau P Largillier R Clippe C	2004	Eur J Cancer2004，40，4：	1
10	Prognostic factors in 1,038 women with metastatic breast cancer显示文摘	Largillier R Ferrero JM Doyen J	2008	Ann Oneol2008，19，12：	1
11	Complete remission obtained with letrozole in a man treated with metastatic breast cancer显示文摘	Italiano A Largillier R Marcy PY	2004	Rev Med Interne2004，25，4：	1
12	Multicentre,phaseⅡstudy evaluating capecitsbine monotherapy in patients with anthracyclineand taxanepmtrceted metastatic breast cancer显示文摘	F umoleau P Largillier R	2004	EurJ Cancer2004，40，4：	1
13	Multicentre,phase Ⅱstudy evaluating Xeloda monotherapy in patients with an-thracycline-and taxane-pretreated metastatic breast cancer显示文摘	Fumoleau P Largillier R Clippe C	2004	Eur J Cancer2004，40，4：	1
14	Early versus late local recurrences after conservative treatment of breast carcinoma:Differences in primary tumor characteristics and patient outcome显示文摘	Courdi A Largillier R Ferrero JM	2006	Oncology2006，71，：	1
15	Prognostic factors in 1038 women with metastatic breast cancer显示文摘	Largillier R Ferrero JM Doyen J	2008	Ann Oncol2008，19，：	1
16	Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer:the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens(GINECO)显示文摘	Lortholary A Largillier R Weber B	2012	Ann Oncol2012，23，2：	1
17	Multicentre, phase Ⅱ study evaluating capecitabine monotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer显示文摘	Fumoleau P Largillier R Clippe C	2004	Eur J Cancer2004，40，4：	1
18	Muhicenter phase Ⅱ trial of neoadjuvant therapy with trastuzumab,docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage Ⅱ or Ⅲ breast cancer: results of the GETN(A)-1 trial显示文摘	Coudert BP Largillier R Arnould L	2007	J Clin Oncol2007，25，19：	1
19	Multicentre, phase II study evaluating capecitabine monotherapy in patients with an- thracycline- and taxane-pretreated metastatic breast cancer 显示文摘	Fumoleau P Largillier R Clippe C	2004	Eur J Cancer2004，40，：	1
20	Multicenter phase I! trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-I trial显示文摘	Coudert BP Largillier R Arnould L	2007	J Clin Oncol2007，25，19：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示